The Medical Advisor

Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. I have two articles and a Video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose IVERMECTIN and CANCER 2024 - NEW STUDIES 2024 Baghli et al - Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024. Co-authors include Dr Paul Marik and Dr William Makis. 2024 Fan et al  - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage ( 2024 Man-Yuan Li et al ) - Ivermectin induces non-protective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells ( 2024 Kaur et al ) - Ivermectin: A Multifaceted drug with a potential beyond anti-parasitic therapy ( 2024 Xing Hu et ...

Contents Basal Cell Carcinoma and Melanoma: Ivermectin and Fenbendazole Breast Cancer (5 cases) Cervical Cancer (2 cases) Colorectal Cancer (4 cases) Esophageal Cancer and Ivermectin Gall Bladder Cancer and Ivermectin Glioblastoma (Brain Cancer) Head and Neck Cancer Lung Cancer (3 cases) Lymphoma: Ivermectin and Mebendazole Neck Cancer and Ivermectin Ovarian Cancer (2 cases) Pancreatic Cancer and Ivermectin (4 cases) Prostate Cancer (2 cases) Rectal cancer and Ivermectin Stomach Cancer and Ivermectin Thyroid Cancer and Ivermectin Turbo Cancer: Ivermectin and Fenbendazole Introduction Ivermectin and its potential role in cancer treatment have sparked significant interest online. Through our research, we've observed that most studies available are preclinical, with a notable lack of published clinical studies. To assist with further investigation, we have compiled and categorized case reports by cancer type in one place. This collection serves as a resource for researchers and those ...